balakotu
★    

India,
2018-05-21 13:31
(1285 d 11:37 ago)

Posting: # 18792
Views: 2,369
 

 Replicate Study design for Brazil [Regulatives / Guidelines]

Dear All,

Brazil submission: Thus any body have any idea on Acceptance off Bio equivalence studies conducted in Replicate study design by ANVISA (Brazil). If acceptable what is the acceptance criteria to be followed (USFDA/Europe Approach).

Regards
Kotu


Edit: No need to post identical text twice within three days. The other post deleted (see the Forum’s Policy). [Helmut]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2018-05-21 16:47
(1285 d 08:21 ago)

@ balakotu
Posting: # 18794
Views: 1,918
 

 ABEL acc. to WHO

Hi Kotu,

» […] Acceptance off Bio equivalence studies conducted in Replicate study design by ANVISA (Brazil).

Replicate designs – although for average bioequivalence – are acceptable for the ANVISA for ages (even mentioned in the guidance).

» […] what is the acceptance criteria to be followed (USFDA/Europe Approach).

If you mean reference-scaling, the latter (actually the WHO’s). See this post. Confirmed by a Brazilian colleague earlier this month.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Weidson
☆    

Brazil,
2018-05-22 20:51
(1284 d 04:16 ago)

@ balakotu
Posting: # 18799
Views: 1,888
 

 Replicate Study design for Brazil

Dear balakotu

The ANVISA have adopted the EMA's Approach. However, for you use this approach you need to convince them that their drug is highly variable. I hope I have helped you.


Best Regards
Weidson C. de Souza


Edit: Post moved. [Helmut]
Activity
 Admin contact
21,778 posts in 4,555 threads, 1,547 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time: Saturday 00:08 CET (Europe/Vienna)

Every new technology to me is like a newborn baby –
and you think that it’s become president
or it’s cure cancer or win a nobel prize.
But in the end, you’re perfectly happy
when it just stays out of jail […].    Eric Betzig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5